Printer Friendly
The Free Library
14,787,278 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA panel backs septic shock treatment.


A committee of outside experts convened by the Food and Drug Administration has endorsed a human antibody, HA-1A, for the treatment of life-threatening bacterial infections.

The panel decided this month that the drug is safe and effective in quenching quenching

Rapid cooling, as by immersion in oil or water, of a metal object from the high temperature at which it is shaped. Quenching is usually done to maintain mechanical properties that would be lost with slow cooling.
 the microbial microbial

pertaining to or emanating from a microbe.


microbial digestion
the breakdown of organic material, especially feedstuffs, by microbial organisms.
 poisons that can kill people infected with gram-negative bacteria. Such bacteria thrive in patients with suppressed immune systems, such as those undergoing chemotherapy. The microbes make endotoxins that can cause the organ failure of septic shock Septic Shock Definition

Septic shock is a potentially lethal drop in blood pressure due to the presence of bacteria in the blood.
Description

Septic shock is a possible consequence of bacteremia, or bacteria in the bloodstream.
.

HA-1A binds to endotoxins, blocking their effects. Earlier this year, researchers reported that the antibody reduced deaths by 39 percent among a group of 200 patients with serious gram-negative infections (SN: 2/16/91, p.100).

Centocor, Inc., of Malvern, Pa., makes HA-1A by culturing genetically engineered genetically engineered adjective Recombinant, see there  human cells in the laboratory. Xoma Corp. of Berkeley, Calif., is using mouse cells to develop a similar drug.
COPYRIGHT 1991 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Food and Drug Administration committee endorses HA-1A antibodies as treatment
Publication:Science News
Date:Sep 21, 1991
Words:143
Previous Article:Gene fix for muscular dystrophy defect. (gene-transfer therapy)
Next Article:Lead's reduced stature. (effects of lead on growth of Mexican-American children)
Topics:



Related Articles
Novel antibodies beat bacterial toxins. (HA-1A, a monoclonal antibody drug used to treat Escherichia coli infection)
Panel backs DDI despite uncertainties. (Food and Drug Administration panel recommends approving AIDS drug didanosine)
AIDS drug finds a booster in FDA panel. (dideoxycytidine) (Brief Article)
(Anti-) septic strategies; new drugs hold promise for treating life-threatening bacterial infections. (Cover Story)
NIH advisers endorse disputed vaccine trial. (National Institutes of Health, gp 120 and gp 160-based vaccine)
Tamoxifen clears hurdle to preventive use.(breast cancer drug)
Immune-Based Therapies: FDA Meeting October 16.
NEW BREAST CANCER HOPE; FDA PANEL BACKS DRUGS TO PREVENT, ATTACK DISEASE.(News)
MINIMED SHARES UP 10 PERCENT; HEARING DATE SET FOR DIABETES DEVICE.(Business)
Home HIV test raises red flags for some.(Health)(Local patients join the FDA in questioning the maker's over-the-counter application)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles